David R.w. Jayne

Director, Aurinia Pharmaceuticals Inc.

Companies

Aurinia Pharmaceuticals Inc.Board member Jan 4, 2021 to Nov 25, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aurinia Pharmaceuticals Inc. AUPH56,499 shares²$932.8K at $16.51Nov 21, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 21, 2024Granted 12,135 shares of Aurinia Pharmaceuticals Inc.²
May 21, 2024Sold 4,946 shares at $5.74 of Aurinia Pharmaceuticals Inc.³
May 23, 2023Sold 8,733 shares at $11.26 of Aurinia Pharmaceuticals Inc.⁴
May 19, 2023Granted 9,310 shares of Aurinia Pharmaceuticals Inc.⁴
May 18, 2023Exercised options 8,733 shares of Aurinia Pharmaceuticals Inc.⁴
May 18, 2022Exercised options 10,000 shares at $3.62 of Aurinia Pharmaceuticals Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAurinia Pharmaceuticals Inc., Board member
2
SEC EDGARAurinia Pharmaceuticals Inc. shares after the filing of Nov 21, 2024
3
SEC EDGARForm 4 filed May 22, 2024
4
SEC EDGARForm 4 filed May 23, 2023
5
SEC EDGARForm 4 filed Jul 11, 2022